Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vassal

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 8, 2014
Lack of GOPC-ROS1 (FIG-ROS1) rearrangement in adult human gliomasL Karayan-Tapon, U Cortes, P Rivet, et al.
Bone Marrow Transplantation|August 1, 1992
Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 childrenV Méresse, O Hartmann, G Vassal, et al.
Bone Marrow Transplantation|November 5, 2003
In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa)J Bouligand, I Boland, D Valteau-Couanet, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantationO Hartmann, D Valteau-Couanet, E Benhamou, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 14, 2000
[What is new in pediatric oncology?]O Oberlin, L Brugières, C Patte, et al.
Cancer Treatment and Research|January 1, 1993
Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy InstituteC Kalifa, H Razafindrakoto, G Vassal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
In vivo potentiation of radiation response by topotecan in human rhabdomyosarcoma xenografted into nude miceP Chastagner, J L Merlin, C Marchal, et al.
Contemporary Clinical Trials|April 24, 2012
Dose-finding designs in pediatric phase I clinical trials: comparison by simulations in a realistic timeline frameworkA Doussau, B Asselain, M C Le Deley, et al.
Bone Marrow Transplantation|June 1, 1991
Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapyD Valteau, O Hartmann, L Brugieres, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1987
Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patientsM Schlumberger, F De Vathaire, J P Travagli, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|July 8, 2014
Lack of GOPC-ROS1 (FIG-ROS1) rearrangement in adult human gliomasL Karayan-Tapon, U Cortes, P Rivet, et al.
Bone Marrow Transplantation|August 1, 1992
Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 childrenV Méresse, O Hartmann, G Vassal, et al.
Bone Marrow Transplantation|November 5, 2003
In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa)J Bouligand, I Boland, D Valteau-Couanet, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantationO Hartmann, D Valteau-Couanet, E Benhamou, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 14, 2000
[What is new in pediatric oncology?]O Oberlin, L Brugières, C Patte, et al.
Cancer Treatment and Research|January 1, 1993
Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy InstituteC Kalifa, H Razafindrakoto, G Vassal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
In vivo potentiation of radiation response by topotecan in human rhabdomyosarcoma xenografted into nude miceP Chastagner, J L Merlin, C Marchal, et al.
Contemporary Clinical Trials|April 24, 2012
Dose-finding designs in pediatric phase I clinical trials: comparison by simulations in a realistic timeline frameworkA Doussau, B Asselain, M C Le Deley, et al.
Bone Marrow Transplantation|June 1, 1991
Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapyD Valteau, O Hartmann, L Brugieres, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1987
Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patientsM Schlumberger, F De Vathaire, J P Travagli, et al.
Pageof 10